From Bluetooth exploits in vehicles to macOS backdoors and GitHub phishing tricks—this week’s threats go deeper than they ...

Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai. The ...